newsfilter
← Latest News
PR Newswire·

Immunic to Participate in Investor, Industry and Scientific Conferences in June

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today...